首页> 外文期刊>Veterinary research >Antiviral effects of ergosterol peroxide in a pig model of porcine deltacoronavirus (PDCoV) infection involves modulation of apoptosis and tight junction in the small intestine
【24h】

Antiviral effects of ergosterol peroxide in a pig model of porcine deltacoronavirus (PDCoV) infection involves modulation of apoptosis and tight junction in the small intestine

机译:Ergosterol过氧化酯在猪Deltacoronavirus(PDCOV)感染中的猪模型中的抗病毒作用涉及小肠中凋亡和紧密结的调节

获取原文
           

摘要

Porcine deltacoronavirus (PDCoV) is a newly discovered swine enteropathogenic coronavirus with worldwide distribution. However, efficient strategies to prevent or treat the infection remain elusive. Our in vitro study revealed that ergosterol peroxide (EP) from the mushroom Cryptoporus volvatus has efficient anti-PDCoV properties. The aim of this study is to evaluate the potential of EP as a treatment for PDCoV in vivo and elucidate the possible mechanisms. Seven-day-old piglets were infected with PDCoV by oral administration in the presence or absence of EP. Piglets infected with PDCoV were most affected, whereas administration of EP reduced diarrhea incidence, alleviated intestinal lesion, and decreased viral load in feces and tissues. EP reduced PDCoV-induced apoptosis and enhanced tight junction protein expressions in the small intestine, maintaining the integrity of the intestinal barrier. EP showed immunomodulatory effect by suppressing PDCoV-induced pro-inflammatory cytokines and the activation of IκBα and NF-κB p65, and upregulating IFN-I expression. Knockdown of p38 inhibited PDCoV replication and alleviated PDCoV-induced apoptosis, implying that EP inhibited PDCoV replication and alleviated PDCoV-induced apoptosis via p38/MAPK signaling pathway. Collectively, ergosterol peroxide can protect piglets from PDCoV, revealing the potential of EP for development as a promising strategy for treating and controlling the infection of PDCoV.
机译:猪Deltacoronavirus(Pdcov)是一种新发现的猪肠致病性冠状病毒,具有全球分布。然而,有效的防止或治疗感染的策略仍然难以捉摸。我们的体外研究表明,来自蘑菇碱加密Volvatus的Ergosterol醇溶溶胶(EP)具有有效的抗PDCOV性能。本研究的目的是评估EP作为PDCOV在体内治疗的潜力,并阐明可能的机制。在EP存在或不存在中,口服给药七天幼鸽用PDCOV感染。感染PDCOV的仔猪受到影响最大,而EP降低的腹泻发生率降低,缓解肠道病变,并降低了粪便和组织中的病毒载量。 EP减少了PDCOV诱导的细胞凋亡,在小肠中增强了紧密结蛋白表达,保持了肠道屏障的完整性。 EP通过抑制PDCOV诱导的促炎细胞因子和IκBα和NF-κBP65的激活来显示免疫调节效果,以及上调IFN-I表达。 P38的敲低抑制PDCOV复制和缓解PDCOV诱导的细胞凋亡,这意味着EP抑制PDCOV复制并通过P38 / MAPK信号通路抑制PDCOV诱导的细胞凋亡。译文中,Ergosterol醇溶溶胶可以保护PDCOV的仔猪保护仔猪,揭示EP作为治疗和控制PDCOV感染的有希望的策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号